SKAN Group (SWX:SKAN) Stock Richly Valued As Margin Recovery Lags Backlog Growth

SKAN Group stock has been on a tear into this earnings print, closing at CHF62.70 and logging a roughly 32% gain over the past three months. That kind of run sets a high bar for a specialised pharma equipment supplier.

The headline from H1 is clear. SKAN Group delivered a sharp reset in profitability with net profit of CHF5.4m and an EBITDA margin of 9.3% on CHF164.5m of net sales. Order intake of CHF247.6m and a CHF442m backlog reflect why the growth story still commands a premium P/E multiple and keep longer term expectations in focus despite the rich share price.

Is SKAN Group at CHF62.70 already pricing in years of earnings expansion, or does the 47x P/E still not reflect the full growth case? Compare the current share price against our valuation analysis for SKAN Group

H1 2026 Earnings Summary

• Revenue, H1 2026 vs. H1 2025: CHF164.5m vs. CHF134.6m (up about 22%)
• Net Income, H1 2026 vs. H1 2025: CHF4.8m profit vs. CHF8.9m loss (swing back to profit)
• Basic EPS, H1 2026 vs. H1 2025: CHF0.21 vs. a loss of CHF0.40 per share (earnings recovery)
• EBITDA Margin, H1 2026: 9.3% on CHF164.5m net sales vs. marginal EBITDA in H1 2025 (profitability improved)

Prefer clean visuals instead of another wall of earnings tables and ratio math? See SKAN Group’s full financial picture, including how the current valuation compares with its fundamentals, in the interactive company report for SKAN Group.

SKAN bullish thesis: backlog, services and margins tested

Bulls argue SKAN Group is turning its order strength and high margin Service & Consumables into durable earnings power. H1 supports parts of that story. Order intake of CHF247.6m and a CHF442m backlog confirm demand has not faded, with Americas orders near CHF100m and management highlighting wins in larger U.S. fill and finish projects. Service & Consumables now account for roughly 39% of net sales and drove about two thirds of sales growth, with EBITDA around CHF13m and a margin near 20.1%. That is consistent with the idea of a growing recurring and higher margin base. Profitability also moved in the right direction, with group EBITDA at CHF15.3m and 9.3% margin and Equipment & Solutions moving back to positive EBITDA. However, the 9.3% margin remains below the 13 to 15% full year target, so the margin recovery story still has work to do.

SKAN bearish thesis: project risk, margins and backlog quality

Bears focus on project timing risk, backlog quality and margin fragility. H1 does not eliminate those concerns. Management again highlighted CHF15 to 20m of backlog that could be cancelled and flagged longer decision cycles and tougher competition. Several major projects now extend into 2028 and some high speed U.S. lines may take longer than the usual 18 to 24 months, which fits the worry that complex projects can slip and cloud revenue visibility. Margin recovery, while real, is not yet secure. The group is still below its 13 to 15% EBITDA margin guidance and Service & Consumables margins softened slightly on mix and timing, showing that even the higher margin parts of SKAN Group are not immune to swings. Guidance was kept unchanged, which challenges the most cautious scenarios, but the print still leaves execution and backlog quality as live risk factors for investors to monitor.

After a sharp backlog build, softer margins and a volatile share price, review whether SKAN Group’s execution risk is isolated. Scan the risk analysis for SKAN Group which shows 1 important warning sign

Take Control Of Your Next Move

If SKAN Group’s mix of a rich P/E multiple, growing backlog and recovering margins has your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch for an entry point that fits your plan. Once you are invested, keep your decisions clear with the Portfolio Command Center that focuses on the most important updates instead of day to day noise. For a longer term view, compare your thinking with thousands of other investors through the Community and see how sentiment is evolving. By spotting potential catalysts and risks early, you give yourself a better chance to stay ahead of the market.

Seeking Alternatives Beyond SKAN Group?

The stocks drawing real breakout momentum rarely stay under the radar for long. Screen fresh ideas before the crowd, while it matters and price gaps are still forming. Act now.

• Spot resilient companies before they start flying by filtering for stable balance sheets and cash flows with the curated list of solid balance sheet and fundamentals stocks (433 results).
• Ride potential trend shifts early as income-focused stocks reset yields and prices using a focused list of 446 dividend fortresses.
• Track where real AI revenue and earnings are already showing up instead of pure hype through a pre-filtered group of 75 profitable AI stocks that aren't just burning cash.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com